
PSA, MRI, biopsy
PSA trend, prostate MRI, biopsy report, Gleason/grade group, and staging notes.
Access a structured urology-oncology route review for PSA, MRI, biopsy, recurrence, and treatment-choice questions. MedChinaNow helps prepare your record set, specialist route, cost questions, and travel plan before you decide.
MedChinaNow turns scattered symptoms, scans, lab results, payment questions, and travel concerns into a structured case file before patients commit to a China hospital route.
After submission, we ask for the minimum report set needed to judge whether a China hospital route is worth pursuing.

PSA trend, prostate MRI, biopsy report, Gleason/grade group, and staging notes.

Robot-assisted surgery, radiotherapy, hormone therapy, PSMA-related questions, or recurrence review.

Self-pay readiness, insurance or employer-sponsored context, and whether offline payment planning should be discussed.
We help organize the record set and route questions so the hospital-doctor discussion can be more useful.
MedChinaNow coordinates records, communication, pricing questions, and travel planning. Treatment suitability, access, pricing, timing, and outcomes must be assessed by the hospital doctor.
If the case is medically reviewable, we can help compare China hospital consultation access, estimate questions, and payment planning relevance. Loan or payment pre-check is only for suitable, verified patients after offline identity, work, insurance, and medical-record review.
Leave diagnosis type, country, email, contact method, and payment route.
We ask for PSA, MRI, biopsy, staging, and prior treatment details.
We organize the case around the treatment route, cost pressure, and timing being compared.
Hospital consultation, estimated cost questions, schedule, translation, and payment-support handoff if relevant.
Keep communication organized after the first review or China visit.
A reliable prostate cancer consultation starts with a clean, organized medical record, not a vague inquiry. U.S. patients often need help structuring scattered reports before discussing surgery, radiotherapy, medication, or recurrence with a specialist.
Estimated pricing can be requested only after the Chinese hospital reviews your biopsy and MRI reports to judge whether a surgical route is relevant.
No. We coordinate records and hospital routes. Treatment decisions must be made by qualified doctors.
No. Submit first. We will tell you which reports make the specialist discussion clearer.
Cross-border cases need record organization, translation, appointment routing, travel planning, and follow-up support.
One short form gives us the medical, timing, and payment context needed to decide whether this route is worth deeper review.